Closed-System Transfer Devices Reduce Exposure to Contaminants

Authors

Ken Maxik
Craig Kimble, Marshall UniversityFollow
Alberto Coustasse, Marshall UniversityFollow

Document Type

Article

Publication Date

3-2023

Abstract

Closed-system transfer devices (CSTDs) are used during the preparation of hazardous drugs (HDs) as a mechanism to reduce the transfer of drugs or vapors into the environment. When evaluating these systems, pharmacists should consider which drugs in the pharmacy would benefit the safety of health care workers and patients using the systems. Medication types include neoplastic agents, such as bleomycin, cisplatin, and methotrexate, and other agents, such as cyclosporine, oxytocin, and progesterone.

Comments

The copy of record is available from the publisher at Closed-System Transfer Devices Reduce Exposure to Contaminants (pharmacytimes.com).

Copyright © 2023 Pharmacy Times.

Recommended Citation

Maxik K., Kimble C., Coustasse A. Closed-System Transfer Devices Reduce Exposure to Contaminants. Pharmacy Times Health System Edition. March, 2023, p. 18 and 20.